Elimination of antipyrine and its metabolites in interferon treated hepatitis C. 1994

J O Sieck, and A el-Yazigi, and H Ali, and M Døssing, and J Saour, and D A Raines, and P Ernst
Department of Medicine, King Faisal Specialist Hospital, Riyadh, Saudi Arabia.

1. To study the effect of interferon on hepatic drug metabolism in chronic hepatitis C, we examined nine patients before and at the end of 6 months of interferon treatment. 2. Routine liver function was determined together with the salivary clearance of antipyrine and the 48 h urinary excretion of the main metabolites of antipyrine: 4-hydroxyantipyrine, 3-hydroxymethylantipyrine and norantipyrine before and after 6 months of interferon treatment. 3. Liver pathology, routine liver function, and antipyrine metabolism remained unchanged after patients were treated for 6 months with interferon for a histologically advanced but clinically compensated chronic hepatitis C.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

J O Sieck, and A el-Yazigi, and H Ali, and M Døssing, and J Saour, and D A Raines, and P Ernst
July 1997, Journal of clinical gastroenterology,
J O Sieck, and A el-Yazigi, and H Ali, and M Døssing, and J Saour, and D A Raines, and P Ernst
January 1978, Folia medica Cracoviensia,
J O Sieck, and A el-Yazigi, and H Ali, and M Døssing, and J Saour, and D A Raines, and P Ernst
October 1995, Hepatology (Baltimore, Md.),
J O Sieck, and A el-Yazigi, and H Ali, and M Døssing, and J Saour, and D A Raines, and P Ernst
December 1994, The Journal of pharmacy and pharmacology,
J O Sieck, and A el-Yazigi, and H Ali, and M Døssing, and J Saour, and D A Raines, and P Ernst
May 1976, Gut,
J O Sieck, and A el-Yazigi, and H Ali, and M Døssing, and J Saour, and D A Raines, and P Ernst
January 1997, Gastroenterologie clinique et biologique,
J O Sieck, and A el-Yazigi, and H Ali, and M Døssing, and J Saour, and D A Raines, and P Ernst
February 1997, Hepatology (Baltimore, Md.),
J O Sieck, and A el-Yazigi, and H Ali, and M Døssing, and J Saour, and D A Raines, and P Ernst
February 1988, British journal of clinical pharmacology,
J O Sieck, and A el-Yazigi, and H Ali, and M Døssing, and J Saour, and D A Raines, and P Ernst
January 2009, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry,
J O Sieck, and A el-Yazigi, and H Ali, and M Døssing, and J Saour, and D A Raines, and P Ernst
January 2010, Klinika oczna,
Copied contents to your clipboard!